In last trading session, 89bio Inc (NASDAQ:ETNB) saw 1.0 million shares changing hands with its beta currently measuring 1.34. Company’s recent per share price level of $11.30 trading at $0.38 or 3.48% at ring of the bell on the day assigns it a market valuation of $1.65B. That closing price of ETNB’s stock is at a discount of -47.17% from its 52-week high price of $16.63 and is indicating a premium of 46.99% from its 52-week low price of $5.99.
For 89bio Inc (ETNB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.22. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.76 in the current quarter.
89bio Inc (NASDAQ:ETNB) trade information
Upright in the green during last session for gaining 3.48%, in the last five days ETNB remained trading in the green while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $11.30 price level, adding 0.09% to its value on the day. 89bio Inc’s shares saw a change of 44.50% in year-to-date performance and have moved 1.07% in past 5-day. 89bio Inc (NASDAQ:ETNB) showed a performance of 79.08% in past 30-days.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 54.8% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 29. It follows that stock’s current price would drop -6.19% in reaching the projected high whereas dropping to the targeted low would mean a loss of -6.19% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -11.24% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -59.99% while estimates for its earnings growth in next 5 years are of -10.60%.
89bio Inc (NASDAQ:ETNB)’s Major holders
RA CAPITAL MANAGEMENT, L.P. is the top institutional holder at ETNB for having 14.18 million shares of worth $113.54 million. And as of 2024-06-30, it was holding 14.1994 of the company’s outstanding shares.
The second largest institutional holder is JANUS HENDERSON GROUP PLC, which was holding about 13.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.2986 of outstanding shares, having a total worth of $106.32 million.
On the other hand, Janus Henderson Global Life Sciences Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 2.97 shares of worth $33.51 million or 2.79% of the total outstanding shares. The later fund manager was in possession of 2.65 shares on Sep 30, 2024 , making its stake of worth around $29.9 million in the company or a holder of 2.49% of company’s stock.
